Status:

RECRUITING

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors

Lead Sponsor:

University of California, Irvine

Collaborating Sponsors:

Memorial Sloan Kettering Cancer Center

National Cancer Institute (NCI)

Conditions:

Testicular Cancer

Eligibility:

MALE

18-39 years

Phase:

NA

Brief Summary

This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aime...

Detailed Description

Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young adulthood. Cohort studies reveal the pr...

Eligibility Criteria

Inclusion Criteria:

  • Age 18 to 39 years at time of consent
  • A confirmed diagnosis of testis cancer (any stage)
  • Completion of chemotherapy for testis cancer within 4 years prior to consent
  • A score of >4 on the Distress Thermometer
  • English fluency, as per medical record documenting preferred language or in the judgment of the investigator
  • Spanish fluency, as per medical record documenting preferred language or in the judgment of the investigator
  • Able to perform informed consent

Exclusion Criteria:

  • Lifetime history of psychiatric of cognitive disturbance as per self-report or medical record
  • In the judgment of the consenting professional, is unable to provide informed consent and complete study sessions and assessment
  • As per self-report, has medical conditions that affect the immune system and would confound immune evaluation (e.g., autoimmune disorder, inflammatory disease; uncontrolled thyroid disease; active infection; myocardial infarction or stroke in the last 6 months; Type I diabetes; acute hepatitis; recent vaccination for viral disease)
  • Regular smoker (daily use)

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2028

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT05836688

Start Date

November 1 2023

End Date

July 1 2028

Last Update

May 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, Irvine

Irvine, California, United States, 92697-3954